Boehringer Ingelheim Receives Positive Opinion for the Use of Ingelvac CircoFLEX + Ingelvac PRRSFLEX for Pig Health Management in the EU
Boehringer Ingelheim’s Cyltezo (biosimilar, adalimumab) Receives the US FDA’s sBLA Approval as the 1st Interchangeable Biosimilar for Multiple Chronic Inflammatory Diseases
Shots:
- The positive opinion recommends the combined use of both vaccines in pig health management. With this, PCVD and PRRS can be prevented with a single injection
- The combination will reduce the number of injections to pigs and support the well-being of animals and the farm economics by saving on costly labor
- The freshly mixed use of Ingelvac CircoFLEX and Ingelvac PRRS MLV is already registered in the US under the tradename FLEX CircoPRRS. The company has launched FLEX CircoPRRS together with the FreVAX needle free smart vaccination device this year
Click here to read full press release/ article | Ref: Boehringer Ingelheim | Image: Pharmaceutical Technology